Result of AGM

10^th May 2017

EKF Diagnostics Holdings plc
("EKF", the "Company")

Result of AGM

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

EKF Diagnostics Holdings plc	www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman	Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO


N+1 Singer (Nomad & Broker)	Tel: 020 7496 3000
Alex Price / Shaun Dobson / Ali Laughton-Scott


Walbrook PR Limited	Tel: 020 7933 8780 or
Paul McManus / Lianne Cawthorne	Mob: 07980 541 893 / 07584 391 303

Back to Listing

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF opens larger facility to increase production of key component for COVID-19 testing regime

EKF’s new facilities in Llandough, Cardiff, for manufacture of PrimeStore^® MTM viral transport media, enabling pathogenic samples to be collected and transported safely and easily in compliance with UN3373 packaging regulations.

EKF fly the extra mile over Christmas

New COVID-SeroKlir SARS-CoV-2 IgG antibody test kit is one of first to detect both the presence and precise levels of COVID-19 neutralizing antibodies

EKF introduces accurate quantitative COVID-19 antibody test kit

New COVID-SeroKlir SARS-CoV-2 IgG antibody test kit is one of first to detect both the presence and precise levels of COVID-19 neutralizing antibodies

EKF launches PrimeStore® MTM pathogenic sample collection and transportation kit

New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza.

PrimeStore® MTM successfully evaluated by Public Health England for SARS-CoV-2 inactivation

Patented transport media manufactured by EKF Diagnostics can help to increase COVID-19 testing capacity